Docherty Anna R, Edwards Alexis C, Yang Fuzhong, Peterson Roseann E, Sawyers Chelsea, Adkins Daniel E, Moore Ashlee A, Webb Bradley T, Bacanu Silviu A, Flint Jonathan, Kendler Kenneth S
Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT, USA.
Virginia Institute for Psychiatric & Behavioral Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Depress Anxiety. 2017 May;34(5):446-452. doi: 10.1002/da.22607. Epub 2017 Feb 2.
The extent to which earlier age of onset (AO) is a reflection of increased genetic risk for major depression (MD) is still unknown. Previous biometrical research has provided mixed empirical evidence for the genetic overlap of AO with MD. If AO is demonstrated to be relevant to molecular polygenic risk for MD, incorporation of AO as a phenotype could enhance future genetic studies.
This research estimated the SNP-based heritability of AO in the China, Oxford and VCU Experimental Research on Genetic Epidemiology (CONVERGE) case-control sample (N = 9,854; MD case, n = 4,927). Common single nucleotide polymorphism heritability of MD was also examined across both high and low median-split AO groups, and best linear unbiased predictor (BLUP) scores of polygenic risk, in split-halves, were used to predict AO. Distributions of genetic risk across early and late AO were compared, and presence of self-reported family history (FH) of MD was also examined as a predictor of AO.
AO was not significantly heritable and polygenic risk derived from the aggregated effects of common genetic variants did not significantly predict AO in any analysis. AO was modestly but significantly lower in cases with a first-degree genetic FH of MD.
Findings indicate that AO is associated with greater self-reported genetic risk for MD in cases, yet not associated with common variant polygenic risk for MD. Future studies of early MD may benefit more from the examination of important moderating variables such as early life events.
发病年龄(AO)提前在多大程度上反映了重度抑郁症(MD)遗传风险的增加尚不清楚。以往的生物统计学研究为AO与MD的遗传重叠提供了不一致的实证证据。如果AO被证明与MD的分子多基因风险相关,将AO作为一种表型纳入研究可能会加强未来的遗传学研究。
本研究在中国、牛津和弗吉尼亚联邦大学遗传流行病学实验研究(CONVERGE)病例对照样本(N = 9854;MD病例,n = 4927)中估计了基于单核苷酸多态性(SNP)的AO遗传力。还在高、低中位数分割AO组中检验了MD的常见单核苷酸多态性遗传力,并使用多基因风险的最佳线性无偏预测值(BLUP)分数对AO进行预测。比较了早发性和晚发性AO的遗传风险分布,并将自我报告的MD家族史(FH)作为AO的预测因素进行了研究。
AO没有显著的遗传力,在任何分析中,由常见遗传变异的综合效应得出的多基因风险都不能显著预测AO。在有MD一级遗传FH的病例中,AO适度但显著较低。
研究结果表明,AO与病例中自我报告的较高MD遗传风险相关,但与MD的常见变异多基因风险无关。早期MD的未来研究可能会从对早期生活事件等重要调节变量的研究中受益更多。